| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8349768 | Pharmacological Reports | 2017 | 29 Pages | 
Abstract
												Our results indicated the potential application of FTY720 in treatment of glioblastoma and demonstrated that inhibition of Nrf2 can enhance the sensitivity of cancer cells to chemotherapeutic drugs.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Biochemistry
												
											Authors
												Li Zhang, Handong Wang, 
											